Ben is the Chief Executive Officer and a Director of KalVista. He joined the Company as Chief Financial Officer in August 2016 and was promoted to the additional role of Chief Business Officer in 2019, followed by President in 2023 and CEO in March 2024. His prior roles include SVP & CFO of Ore Pharmaceutical Holdings (Nasdaq: ORXE) and Penwest Pharmaceuticals Co. (Nasdaq: PPCO), and a decade as an investment banker at firms including Robertson Stephens. Before his business career, Ben served as a Naval Aviator in the U.S. Navy.
Ben holds a BA in Quantitative Economics from Tufts University as well as an MBA in Finance and an MA in International Relations from the University of Chicago.
